Literature DB >> 8985691

The model of pentylenetetrazol-induced status epilepticus in the immature rat: short- and long-term effects.

A Nehlig1, A Pereira de Vasconcelos.   

Abstract

In order to assess acute, short and long-term effects of seizures in the immature rat brain, we studied the metabolic, circulatory and histopathological changes induced by pentylenetetrazol (PTZ) given at postnatal day 10 (P10) or 21 (P21). Seizures were induced by repetitive subconvulsive injections of PTZ given as a first dose of 40 mg/kg followed 10 min later by 20 mg/kg. Thereafter, rats received every 10 min additional injections of PTZ 10 mg/kg until the onset of status epilepticus. Local cerebral metabolic rates for glucose (LCMRglc) were measured both during the seizures in P10 and P21 rats and in the young adult animal at P60 by means of the quantitative 2-deoxyglucose technique. Rates of local cerebral blood flow (LCBF) were determined during the seizures by the iodoantipyrine technique. Short-term histological changes were assessed by acid fuchsin and hematoxylin-eosin staining and by HSP72 immunohistochemistry. At P10, LCMRglcs uniformly increased (38-400%) over control values during seizures. At P21, metabolic increases (39-181%) occurred only in 20% of the structures while LCMRglcs decreased in most cortical, hippocampal and sensory areas as well as in mammillary body, discrete thalamic nuclei and white matter areas. At P10, LCBF rose (32-184%) in all brain structures whereas, at P21, LCBF decreased in cortical, hippocampal and sensory regions and increased in most other areas. At P60, in animals having seized at either age, significant long-term decreases in LCMRglcs were recorded in hippocampus, auditory and piriform cortex, medial geniculate body and mammillary body. In P60 animals exposed to PTZ at P10, LCMRglcs were also decreased in 3 other sensory areas. In P60 animals exposed to seizures at P21, LCMRglcs were additionally decreased in sensory regions, cortices, thalamic and hypothalamic regions. Neuronal cells were transiently stained with acid fuchsin, with a peak occurring at 24 h after the seizures. The stain was visible in all regions of cerebral cortex and hippocampus and in some thalamic and hypothalamic nuclei. This transient staining was not accompanied by cell degeneration as assessed by hematoxylin-eosin histology. No HSP72 expression could be detected 24 h after the seizures, neither at P10 nor at P21. The present study shows that the immature rat neurons undergo altered metabolic rates and local circulatory decreases in the acute phase, a change in the affinity of acid fuchsin as a short-term effect and long-term metabolic decreases. All these changes are located in the same regions, i.e., cerebral cortex, hippocampus, sensory regions as well as scattered thalamic and hypothalamic nuclei. Thus, short- and long-term metabolic changes induced by seizures can be used as an index of cell stress in the immature rat brain. Since all these changes occur in the absence of visible neuronal death, they might be related to changes in the final arborization and synaptic organization of the developing brain.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8985691     DOI: 10.1016/s0920-1211(96)00045-9

Source DB:  PubMed          Journal:  Epilepsy Res        ISSN: 0920-1211            Impact factor:   3.045


  10 in total

Review 1.  Lessons from the laboratory: the pathophysiology, and consequences of status epilepticus.

Authors:  Karthik Rajasekaran; Santina A Zanelli; Howard P Goodkin
Journal:  Semin Pediatr Neurol       Date:  2010-09       Impact factor: 1.636

2.  Status epilepticus causes necrotic damage in the mediodorsal nucleus of the thalamus in immature rats.

Authors:  H Kubová; R Druga; K Lukasiuk; L Suchomelová; R Haugvicová; I Jirmanová; A Pitkänen
Journal:  J Neurosci       Date:  2001-05-15       Impact factor: 6.167

3.  Interleukin-1 Receptor in Seizure Susceptibility after Traumatic Injury to the Pediatric Brain.

Authors:  Bridgette D Semple; Terence J O'Brien; Kayleen Gimlin; David K Wright; Shi Eun Kim; Pablo M Casillas-Espinosa; Kyria M Webster; Steven Petrou; Linda J Noble-Haeusslein
Journal:  J Neurosci       Date:  2017-07-19       Impact factor: 6.167

4.  Region-specific vulnerability to endoplasmic reticulum stress-induced neuronal death in rat brain after status epilepticus.

Authors:  Jing Chen; Hu Guo; Guo Zheng; Zhong-Nan Shi
Journal:  J Biosci       Date:  2013-12       Impact factor: 1.826

Review 5.  Is neuronal death required for seizure-induced epileptogenesis in the immature brain?

Authors:  Tallie Z Baram; Mariam Eghbal-Ahmadi; Roland A Bender
Journal:  Prog Brain Res       Date:  2002       Impact factor: 2.453

6.  Mossy fiber plasticity and enhanced hippocampal excitability, without hippocampal cell loss or altered neurogenesis, in an animal model of prolonged febrile seizures.

Authors:  Roland A Bender; Celine Dubé; Rebeca Gonzalez-Vega; Erene W Mina; Tallie Z Baram
Journal:  Hippocampus       Date:  2003       Impact factor: 3.899

7.  Animal models for the development of new neuropharmacological therapeutics in the status epilepticus.

Authors:  Ed Martín; Ma Pozo
Journal:  Curr Neuropharmacol       Date:  2006-01       Impact factor: 7.363

Review 8.  Long-term neuropathological and behavioral impairments after exposure to nerve agents.

Authors:  Vassiliki Aroniadou-Anderjaska; Taiza H Figueiredo; James P Apland; Eric M Prager; Volodymyr I Pidoplichko; Steven L Miller; Maria F M Braga
Journal:  Ann N Y Acad Sci       Date:  2016-03-22       Impact factor: 5.691

9.  Peroxisome proliferator-activated receptor-γ agonist inhibits the mammalian target of rapamycin signaling pathway and has a protective effect in a rat model of status epilepticus.

Authors:  Yong-Zhi San; Yu Liu; Yu Zhang; Ping-Ping Shi; Yu-Lan Zhu
Journal:  Mol Med Rep       Date:  2015-04-17       Impact factor: 2.952

10.  Reference Gene Validation in the Brain Regions of Young Rats after Pentylenetetrazole-Induced Seizures.

Authors:  Alexander P Schwarz; Anna A Kovalenko; Daria A Malygina; Tatiana Y Postnikova; Olga E Zubareva; Aleksey V Zaitsev
Journal:  Biomedicines       Date:  2020-07-23
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.